GE Capital, Healthcare Financial Services (HFS) has named Brett B. Haring leader of its Life Sciences Finance business, which has committed more than $2.3 billion in debt and equity financing to 500+ emerging healthcare companies since 2000.

A 25-year GE Capital veteran, Haring began his career in GE Capital’s equipment finance business and went on to hold roles of increasing responsibility. He was most recently senior managing director of GE Capital’s Corporate Finance business for the U.S. eastern region before moving to San Francisco in 2009 to run its western U.S. region. He’ll continue to be based in the Bay Area in his new role.

Since its formation in 1988, the Life Sciences Finance business has been a leader in financing early-stage biotech, pharma and device companies, with significant relationships across the venture capital community that specializes in healthcare.

“Brett has a long history of providing outstanding leadership and developing innovative solutions for customers,” said Darren Alcus, president and CEO of HFS. “With Brett’s energy and experience, we look forward to fortifying our relationships with our venture capital partners and continued growth in this important space.”

“The life sciences space is extremely exciting,” said Haring. “These are relatively young companies that are working to solve problems that are crucial for the health of our society. I look forward to continuing to grow the business and furthering our commitments to the life science industry while also leveraging GE's deep domain expertise in healthcare.”

GE Capital’s Healthcare Financial Services (HFS) business is one of the most active capital providers in the U.S. healthcare market, deploying approximately $9 billion in new commitments to customers via 200+ transactions in 2013. That adds up to more than $65 billion in financing over the past ten years.